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Dobutamine increases diaphragmatic contractility in dogs
The effects of dobutamine on diaphragmatic contractility were studied in 24 Respiratory muscle dysfunction has recently been regarded to play an important role in the pathogenesis of respiratory failure by leading to ventilatory pump failure.l'2 In clinical practice, ventilatory failure seen in patients with acute exacerbations of chronic obstructive pulmonary disease (COPD), 3 neuromuscular disease, malnutrition 4 and circulatory shock 5 is related to respiratory muscle dysfunction. To treat these patients, several pharmacological agents have been used in an attempt to improve the contractility and endurance of respiratory muscles, especially the diaphragm. So far, methylxanthine compounds and sympathomimetic amines have been reported to have positive inotropic effects on the diaphragm. Methylxanthine compounds, such as caffein 6 and theophylline 7-9 possess a direct potentiating effect on diaphragmatic contractility. The effects of sympathomimetic amines are more controversial.
During an infusion of dobutamine (10 tzg "kg -I "min-l for 20 rain), Pdi increased by 15 +--2.1% of control value at 20 Hz stimulation ( P < 0.01), and by 13 +_ 1.2% at 100 Hz stimulation (P < 0.01). The Edi was not altered by dobutamine infusion. This enhancement of Pdi by dobutamine was abolished by simultaneous infusion of nicardipine, a Ca
The 132 sympathomimetics such as isoproterenol, I~ terbutaline ~ and fenoterol, ~2 are known to have an inotropic effect on fatigued diaphragm in dogs, while having no effect on fresh diaphragm. Dopamine at the dose of 10 Ixg' kg -l" min -l, which is expected to have mainly 131 adrenergic effect, increased transdiaphragmatic pressure (Pdi) in patients with COPD during acute respira-tory failure. ]3 As an explanation for the mechanisms of these drugs, 132 stimulants are thought to increase the contractility of the fast-contracting fibres which are susceptible to the process of fatigue, while 131 stimulants are considered to act by increasing the diaphragmatic blood flow and the energy supply to the muscles.
However, salbutamol, a selective 132-adrenergic agonist, does not exert a remarkable inotropic effect even on fatigued diaphragm, 14 and there still remains much to be investigated to clarify the mechanisms of action of these drugs. In this present study, we investigated the effects of dobutamine, another sympathomimetic amine possessing B I adrenergic effects, on diaphragmatic contractility in anaesthetized dogs. In addition, we evaluated the effects of two kinds of vasodilating agents, prostaglandin E l (PGEI) and nicardipine, on diaphragmatic contractility when they are combined with dobutamine, in order to find the mechanism of dobutamine on the diaphragm.
Methods
With institutional review board approval, in 24 mongrel dogs weighing 10 to 18 kg, anaesthesia was induced with 20 mg-kg -I of ketamine im and maintained with 4 mg. kg -I. hr -I of secobarbital iv during the course of experiment. The tracheas were intubated with a cuffed tracheal tube and the lungs were mechanically ventilated with air and oxygen to keep Pat 2 around 100 mmHg and PaCt 2 between 35 and 40 mmHg. Metabolic acidosis, if any, was corrected with iv sodium bicarbonate. The right femoral artery was cannulated to monitor blood pressure and to obtain blood samples for arterial blood gas analysis and electrolyte measurement. The right femoral vein was cannulated for the administration of dobutamine, PGE I or nicardipine, and the left femoral vein for the administration of secobarbital and fluid (10 ml-kg -l. hr-i of Ringer's lactate solution). A Swan-Ganz catheter was inserted via the fight external jugular vein for cardiac output measurement. Rectal temperature was monitored continuously and maintained at 37 ---1 ~ C.
The phrenic nerves were exposed bilaterally in the neck and stimulating electrodes were placed around the fifth and sixth roots. Two thin-walled latex balloons were positioned in the stomach and in the middle third of the oesophagus to measure gastric (Pga) and oesophageal pressure (Peso), respectively. Balloons were connected to a differential pressure transducer to obtain Pdi (= PgaPeso). Supramaximal stimuli (10-15 volts) of 0.1 ms duration lasting 2 sec were applied to the phrenic nerves at frequencies of 10, 20, 50 and 100 Hz. Diaphragmatic contractility was evaluated by measuring the maximal Pdi generated in response to electro-phrenic stimulation with the airway closed at FRC level while mechanical ventilation was stopped. An abdominal binder was closely placed Interventions. around the abdomen and lower rib cage to avoid distension of the abdomen during stimulation. Transpulmonary pressure, the difference between airway and oesophageal pressures, was kept constant when the airway was closed at FRC to maintain the same lung volume. The electrical activity of the diaphragm was measured with needle electrodes inserted percutaneously into the right hemidiaphragm from the upper abdominal area, and was rectified and integrated with a leaky integrator (TYPE 1310, Nihondenki San-ei) with a time constant of 0.1 sec. This was regarded as the integrated diaphragmatic electrical activity (Edi).
As a pilot study, we measured the changes in Pdi and Edi in response to 1 to 10 Ixg" kg -l 9 min -l of dobutamine, 1 i~g. kg -l 9 min -I ofPGE I and 5 I~g" kg -I 9 min -1 of nicardipine respectively.
In the present study, after the baseline measurements of Pdi, Edi and haemodynamics which included mean arterial pressure (MAP) and cardiac output (CO), a dobutamine infusion was started at the dose of 10 ixg. kg -I 9 min -t. The second set of measurements was done 20 rain after the initiation of dobutamine infusion. Thereafter the animals were randomly assigned to two groups to receive either infusions of PGE l (defined as PGE 1 group, n = 12), or nicardipine (defined as NIC group, n = 12), while the dobutamine infusion was continued at the same rate. The dosages of these vasodilators were adjusted to decrease MAP to around 100 mmHg. After the target MAP was obtained, the third set of measurements was performed. Subsequently the measurements were repeated, once at 20 min after the infusion of PGE I or nicardipine was stopped, and again at 20 min after the dobutamine infusion was stopped. Intervals between each measurement took approximately 30 min, and therefore the whole experiment lasted about 120 min (Figure 1 ). 
Results

Effects of dobutamine, PGE 1, and nicardipine on haemodynamics
The dobutamine infusion at 10 ~g. kg -~ 9 min -1 resulted in an increase in MAP and CO in both PGE I and NIC groups (P < 0.05). With the infusion of either PGE l or nicardipine together with dobutamine, MAP was decreased to approximately the same level in both groups. The dosages of these vasodilating agents to achieve MAP around 100 mmHg were 0.5 to 1 I~g" kg -l" min -1 for PGE l, and 1 to 5 l~g" kg -I "min -1 for nicardipine. The CO did not change significantly by the infusion of PGE l or nicardipine. Soon after the PGE l infusion was stopped, MAP returned to the pre-PGE I level; however the lowered MAP caused by nicardipine remained even 20 rain after the cessation of nicardipine infusion. The MAP and CO in both groups returned to the control level 20 min after dobutamine infusion was stopped (Table I) .
Effects of dobutamine, PGE I and nicardipine on diaphragmatic contractility
In the pilot study, we confirmed that dobutamine at the dose of 1 to 10 i~g. kg -l 9 min -1 showed an increase in Pdi in a dose dependent manner, but PGE 1 or nicardipine alone did not influence Pdi.
In the present experiment, Pdi increased with dobutamine infusion (P < 0.05). These changes were observed at each frequency of stimulation. Since no vasodilators were given at this time, changes in Pdi during dobutarnine infusion were calculated together for the two groups. Consequently, Pdi increased by 15 • 2.1% of control value for 20 Hz stimulation (P < 0.01), and by 13 __. 1.2% for 100 Hz stimulation (P < 0.01). However, there was no change in Edi. During the infusion of PGE l together with dobutamine, Pdi did not show any significant change. On the other hand, nicardipine infusion combined with dobutamine lowered Pdi to pre-dobutamine level, and Pdi during the infusions of these vasodilators differed between the groups (Table II) (P < 0.05). Typical recordings of Pdi (20 and 100 Hz) are shown in Figure 2 . After the infusion of the vasodilating agents was stopped, Pdi returned towards the values during dobutamine infusion. Twenty minutes after the cessation of dobutamine infusion, Pdi returned to the control level. Edi did not show any remarkable changes throughout the experiment.
Discussion
The main findings of this study are; (1) 10 i~g-kg -t. min -~ dobutamine, the dose used in clinical practice, increased contractility of the canine diaphragm, (2) the potentiating action of dobutamine on canine diaphragm was reversed by the simultaneous infusion of nicardipine, but was not influenced by the infusion of PGEj, (3) the decrease in MAP with nicardipine and PGE l were similar. We observed that Pdi was increased by the administration of dobutamine without any change in Edi. This implies that contractility of the muscle was increased by dobutamine in response to the same amount of neural stimulation. The Pdi can also be dependent on the initial length of the muscle fibres and a major determinant of the length of the diaphragm is lung volume. Therefore, we stimulated the phrenic nerves with the airway closed at FRC level, and tried to keep the transpulmonary pressure constant at FRC level throughout the experiment. On the basis of our observations that the drugs administered did not change the initial lung volume and that Edi did not change throughout the whole experiment, the changes in Pdi are considered to reflect the changes in contractility of the diaphragm.
The effects of sympathomimetic amines on skeletal muscle have been studied extensively. The direct effect of these amines on skeletal muscle is considered to be mediated via 132 receptors, and their effect is largely dependent on the type of fibres involved : slow-contracting muscles show a decrease in tension and duration of maximum twitch responses, while fast-contracting muscles 15 respond with an increase in tension and duration. Therefore, the net effect of these amines on skeletal muscle contractility depends on the distribution of these muscle fibres. In regard to their actions on respiratory muscles, there have been several studies of the effect of 132 sympathomimetic amines on the canine diaphragm. Isoproterenol,I 0 terbutaline I l and fenoterol 12 increased Pdi of fatigued diaphragm, but did not affect Pdi of nonfatigued diaphragm. Since the canine diaphragm is composed of almost equal amounts of both slow-and fastcontracting fibres, '6 the effects of 132 sympathomimetic amines on muscle fibres may have counteracted each other, resulting in no change in Pdi for nonfatigued diaphragm. However, in the fatigued diaphragm, their actions on fast-contracting fibres, which are more susceptible to the process of fatigue and decrease in contractility, may have been unmasked, resulting in an increase in contractility as a whole.
In the present study, dobutamine in a dose of 10 Ixg" kg -l" min -t, which possesses mainly 131 adrenergic action, 17 showed a potentiating effect on canine diaphragmatic contractility. This effect of dobutamine could have been mediated either by the direct action of the drug on the diaphragm or by increasing blood flow to the diaphragm. However, 131 sympathomimetic amines do not seem to affect the contractility of diaphragm directly. Aubier et al. administered dopamine (10 t~g" kg -I 9 min -I) to the patients with COPD during acute respiratory failure and found that the Pdi in response to electro-phrenic stimulation increased by 30%. At the same time, they evaluated diaphragmatic blood flow and found a concomitant increase in diaphragmatic blood flow. Therefore, they suggested that the increase in diaphragmatic contractility was the result of increased diaphragmatic blood flow.t3
We did not measure diaphragmatic blood flow in the present study. Instead, we investigated the changes in systemic haemodynamic variables in response to dobutamine, PGEj and nicardipine. The increased CO with dobutamine did not change with either of these vasodilators, but the elevated MAP produced by dobutamine was decreased by these vasodilators to similar levels. There were no differences in CO and MAP between the two groups while these vasodilators were infused during dobutamine infusion. From our previous study, diaphragmatic blood flow changes in parallel with changes in CO. t8 It has been reported that diaphragmatic blood flow is maintained constant with MAP above 70 mmHg. 19 There is also another report stating that diaphragmatic blood flow is dependent on MAP. 2~ In any case, under the conditions where CO and MAP are maintained at approximately the same level, a difference in diaphragmatic blood flow is not likely to occur while these two different vasodilators are given. Besides, it is also unlikely that PGE l or nicardipine would act on phrenic arteries in a different manner. Therefore, we postulate that the effect of dobutamine on diaphragm is not due to changes in blood flow to the diaphragm.
Digoxin was shown to augment diaphragmatic contractility in dogs 21 and in patients with COPD. 22 Digoxin is known to have an inotropic effect on the myocardium but not on skeletal muscle. 23 Digitalis inhibits Na+-K+-ATPase at the cell membrane level, which will augment cell entry of calcium. This influx of calcium will then increase the contractile strength of the myocardium. However, movement of extracellular calcium across the cell membrane during the action potential plays a minor role in determining contractile strength in skeletal muscle, with all the needed calcium being liberated from the sarcoplasmic reticulum. However, extracellular calcium has been shown to be necessary for diaphragmatic contraction but not for contraction of other skeletal muscle such as hindlimb muscle. 24 This finding suggests that the diaphragm behaves more like cardiac muscle. We postulate that dobutamine exerted a positive inotropic action on the diaphragm in the same manner as digoxin, and that may explain why nicardipine inhibited the effect of dobutamine. Inhibited calcium influx caused by nicardipine may have decreased diaphragmatic contractility. In the pilot study we did not observe a negative inotropic effect of nicardipine alone on diaphragm. However, with a larger dose than was used in the pilot study, nicardipine might, like 9 verapamil, have reduced diaphragmatic contractility. In summary, dobutamine infusion of 10 Ixg" kg -1 9 min -l increased diaphragmatic contractility in dogs and this effect was abolished by the simultaneous infusion of nicardipine but not of PGE 1. These results suggest that the mechanism of dobutamine may be related to increased influx of calcium ion. To apply the results of the present study to clinical situations, the effects of dobutamine administration on fatigued diaphragm as well as in patients with diaphragmatic dysfunction should be investigated.
